Sounds lovely.
But $100 SP would give a MC of $800B.
The largest biotech in the world currently has a MC less than that.
Merck, Roche, Pfizer and Novartis all combined currently have a total MC around US$800B MC. And they have some blockbuster drugs both in oncology and other spaces (such as the lucrative cholesterol lowering drugs).
An $8-40B takeover ($1-5 SP) within the next 3-5 years? Maaayyyybe.
Or if Imugene fend off TOs and contine for the next 5-10 years then maybe be amoung some of those big biotechs if we have a good market share in multiple indications, some through licensing agreements, some kept in-house.
IMO of course.
Media Thread, page-12968
-
- There are more pages in this discussion • 1,367 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.002(3.64%) |
Mkt cap ! $417.2M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.9¢ | 5.5¢ | $1.176M | 20.89M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1135235 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 477220 | 6 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |